Suppressor of cytokine signaling 3 is down-regulated by BCR-ABL and results in loss of JAK2 V617F in a patient with concurrent BCR-ABL translocation and JAK2 V617F mutation
Document Type
Article
Publication Date
1-1-2010
Publication Title
Haematologica-The Hematology Journal
Recommended Citation
Ang, C.H.; Gan, G.G.; and Nadarajan, V., "Suppressor of cytokine signaling 3 is down-regulated by BCR-ABL and results in loss of JAK2 V617F in a patient with concurrent BCR-ABL translocation and JAK2 V617F mutation" (2010). Research Publications (2006 to 2010). 4053.
https://knova.um.edu.my/research_publications_2006_2010/4053
Volume
95
Issue
2
Publisher
Ferrata Storti Foundation
Publisher Location
VIA GIUSEPPE BELLI 4, 27100 PAVIA, ITALY
Additional Information
15th Annual Meeting of the European-Hematology-Association, Barcelona, SPAIN, JUN 10-13, 2010
COinS